Hasten Biopharmaceutic是中国生物制药领域的一个全新名字;根据商业登记信息,该公司成立于今年9月中旬,由中国合肥市政府经营的生物制药投资公司Ray CapitalManagement出资。
#药闻简讯#2023年4月20日,-- 中国制药公司Hasten Biopharmaceutic(海森生物医药)在亚洲最大的医疗投资公司CBC集团和阿布扎比主权财富基金Mubadala投资公司共同领导的一轮筹资中筹集了3.15亿美元。
Chinese firm Hasten Biopharmaceutic hasraised $315m for business development of its pipeline assetsin a financing roundco-led by Singapore-based CBC Group and Abu Dhabi sovereign wealth fund Mubadala Investment, The funding round was supported by additional institutional investors. Hasten will also use...
Chinese firm Hasten Biopharmaceutic hasraised $315m for business development of its pipeline assetsin a financing roundco-led by Singapore-based CBC Group and Abu Dhabi sovereign wealth fund Mubadala Investment, The funding round was supported by additional institutional investors. Hasten will also use...
(RTTNews) - Takeda Pharmaceutical Company Ltd. (TAK), on Monday, said it entered into an agreement to divest a portfolio of non-core prescription pharmaceutical products sold in China to Hasten Biopharmaceutic Co., Ltd. (China) for US$322 million. The portfolio to be divested to Hasten inc...
仿制药参比制剂数据库提供了注射用生长抑素参比制剂的详细信息,包括原研进口,增加变更后上市许可持有人Hasten Biopharmaceutic (Switzerland) AG的商品名Stilamin(思他宁),英文名称Somatostatin For Injection,序号,规格,剂型,持证商Merck(Schweiz)Ag/Hasten Biopharmace